Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Transcript of Biothermatics
Product Name News Release Biothermatics Inc. has recently completed research and development on the iTherm technology. This product effectively uses hyperthermia treatment to reduce the size of cancerous tumors. The technology is not meant to completely treat the cancer, but it does drastically improve the lifestyle of patients that are under radiation or chemotherapy by lowering the necessary dosages of these poisonous treatments.
Biothermatics is dedicated to improving the well-being of patients plagued with various forms of cancer through this non-invasive, inexpensive, and completely effective treatment option. The product has been tested at top-tier universities on both animals and humans and has shown consistently positive results. Biothermatics plans to continue research towards more progressive methods of reducing the pain associated to overcoming cancer.
Simple Value Network Next Major Milestone: Human Market
IP position needs to move towards patents
Unit Sales: 15
Unit Price: 35,000
Net Profit: 243,000 Physical Architecture Operational Architecture Validation Conceptual Validity
Ensure iTherm remains easy to operate and portable
Ensure that the price remains under $5000.
Make sure that any new objectives added are immediately given requirements.
check with stakeholders for response to possible design changes
Test to ensure that the iTherm heats tissue to the required levels
Operational Concept Provide hyperthermia
Reduce treatment time
Maintain safe and measurable operating levels